<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Supriya Lifescience Ltd has filed its annual initial disclosure with the stock exchanges confirming that it does not qualify as a 'Large Corporate' under SEBI's framework for entities raising debt securities. The company reported outstanding borrowings of Nil as on the applicable reporting date. Its highest credit rating during the previous financial year was A+. The disclosure was filed on April 30, 2026, signed by the Company Secretary and CFO, in line with SEBI circulars from August 2021, April 2022, and October 2023.
This is a routine compliance filing with no negative implication. The zero outstanding borrowings signal that the company is debt-free as of the reporting date, which is generally a positive indicator for shareholders.